PT 141 dosing is 1.75 mg injected for the FDA-approved form, while off-label research ranges run 1 mg to 2 mg. Here's how timing, route, and safety differ.
PT 141 dosing for the only FDA-approved version, Vyleesi, is 1.75 mg injected under the skin at least 45 minutes before anticipated sexual activity. That dose is approved only for premenopausal women with hypoactive sexual desire disorder (HSDD), and it should not be used more than once every 24 hours or more than eight times per month. Off-label and research use looks different, with reported doses ranging from about 1 mg to 2 mg injected and 10 mg or more delivered as a nasal spray.
What PT-141 Is and Why Dosing Varies
PT-141 is the research name for bremelanotide, a melanocortin receptor agonist that acts on the brain and central nervous system rather than on blood flow. It is not a PDE5 inhibitor, and it does not work the same way as sildenafil, tadalafil, or testosterone therapy.
Bremelanotide is FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women, and it is not approved for men or for any other indication in the United States.
Because approval is narrow, most dosing information for other groups comes from small trials, discontinued nasal spray studies, and user reports. That is why there is no single agreed-upon pt-141 dosage for everyone.
PT-141 Dosing by Route of Administration
Route changes everything. An injected dose is absorbed consistently, while a nasal dose depends on spray volume, technique, and how much of the drug crosses the nasal lining.
| Route | Typical reported dose | Timing | Key notes |
|---|---|---|---|
| Subcutaneous injection (Vyleesi, FDA-approved) | 1.75 mg | At least 45 minutes before | Maximum one dose per 24 hours, eight per month |
| Subcutaneous injection (off-label or research) | 1 mg to 2 mg | 30 to 60 minutes before | Users often start low to check tolerance |
| Nasal spray (early clinical studies) | 10 mg | 30 to 60 minutes before | Development shifted to injection due to blood pressure effects |
| Compounded nasal spray | Varies widely, often 1 mg to 2 mg per spray | 30 to 60 minutes before | Not FDA-approved; concentration depends on the source |
The gap between 1.75 mg injected and 10 mg intranasal reflects how poorly the nasal route absorbs the drug. It is not a sign that nasal use is stronger.
PT-141 Dosage for Women and Men
The approved pt-141 dosage for women is 1.75 mg by subcutaneous injection, and it applies only to premenopausal women with HSDD. There is no approved dose for postmenopausal women and no approved dose for men.
Men who use PT-141 do so entirely off-label. Reports of pt-141 for men usually describe injections in the 1 mg to 2 mg range, with effects noticed mostly on desire and arousal rather than on erection hardness.
Small early studies did show some erectile response in men, but the effect was modest compared with established ED treatments. Anyone considering PT-141 for male use should treat it as an experimental option and discuss it with a clinician.
How Long Does PT-141 Last?
The practical answer to how long does pt-141 last is usually two to six hours, while the plasma half-life is about 2.7 hours. Effects typically begin within 30 to 60 minutes and peak over the first couple of hours.
That timeline shapes planning. Taking a dose too early means the effect may fade before it is needed, and taking the drug too late means waiting through the onset window.
Frequency limits matter as much as timing. The label caps use at one dose per 24 hours and no more than eight doses per month, largely because of blood pressure changes and the risk of focal melanosis with repeated exposure.
Side Effects and Safety Considerations
Nausea is the most commonly reported side effect of PT-141, appearing in roughly 40 percent of participants in clinical trials of the injected form. Flushing, headache, and injection site reactions are also common.
- Blood pressure: PT-141 can raise blood pressure temporarily, and it is contraindicated in people with uncontrolled hypertension or known cardiovascular disease.
- Focal melanosis: Darkening of the gums, skin, or breast tissue has been reported with repeated use.
- Interactions: Combining PT-141 with blood pressure medications, alcohol, or other vasoactive drugs may worsen side effects.
- Pregnancy: PT-141 is not recommended during pregnancy or breastfeeding.
Anyone with heart disease, kidney or liver problems, or a history of melanoma should not use PT-141 without medical supervision. Dosing errors with compounded products have caused severe nausea and blood pressure spikes.
Sourcing and Storage Questions
Where to buy pt-141 is one of the most common questions, and the only legally available version in the United States is prescription Vyleesi. Research chemical listings and compounded sprays are not FDA-approved, so purity and actual concentration are unknown.
Some users try to prepare a nasal version from lyophilized powder, which means reconstituting the peptide and transferring it into a spray bottle. That process carries real risks of contamination, inaccurate concentration, and dosing mistakes.
Storage depends on the form. Lyophilized powder should stay refrigerated at 2 to 8 degrees Celsius and is generally stable for months, while many suppliers recommend using a reconstituted solution within about four weeks when refrigerated. A cloudy vial, or one left at room temperature for days, should be discarded.
PT-141 is a prescription medication for a specific population, and self-dosing with unregulated products is the main source of avoidable harm.
Frequently Asked Questions
What is the standard PT-141 dose?
The only FDA-approved dose is 1.75 mg injected subcutaneously, taken at least 45 minutes before anticipated sexual activity. It is approved only for premenopausal women with hypoactive sexual desire disorder and is limited to one dose per 24 hours and eight doses per month. Off-label doses reported in men range from about 1 mg to 2 mg, but no male dose is approved.
How long before sex should I take PT-141?
The label directs users to inject at least 45 minutes before anticipated activity. Many people report noticeable effects starting 30 to 60 minutes after dosing, with a usable window lasting roughly two to six hours. Dosing too early can mean the effect fades before it is needed.
Is PT-141 available over the counter?
No. PT-141 is available in the United States only by prescription, under the brand name Vyleesi. Research chemical and compounded nasal products sold online are not FDA-approved, so their strength and purity are not verified. Buying from unregulated sources is a leading cause of dosing errors and adverse effects.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.